Capstone Holding shareholders back cut in authorized common shares to as low as 5,000,000
Bitget2026/09/30 21:22- Capstone Therapeutics’ board adopted resolutions on Aug. 7, 2026 to pursue amendments cutting authorized common and preferred shares.
- Shareholders holding 56.4% of voting power delivered written consent the same day, clearing both actions without a meeting.
- Board gained authority to exchange Series Z 8% Non-Convertible Preferred Stock and accrued management fees for up to 15,750,000 common shares.
- Exchange pricing set at 103% of the Nasdaq Official Closing Price before each transaction; recipients to sign 18-month lock-ups.
- Actions take effect no earlier than 20 days after the information statement is mailed on or about Oct. 6, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bloomberg Economists: Anthropic's IPO May Signal the End of the AI Boom
Bloomberg economist Anna Wong believes that Anthropic's actual price per million tokens has dropped significantly since September. Although token usage has surged, its market share has actually declined, indicating that its technological edge has not translated into lasting pricing power. An IPO would bring the pricing and profit margins of cutting-edge AI into the public market for quarterly scrutiny; if its pricing power is weaker than what is implied by its valuation, the AI sector might see an accelerated correction in valuations.
Cosan Publishes Q3 2026 Earnings Call Transcript